Analisis Sistem Manajemen Logistik Obat di Klinik Altara Simalingkar

Drug logistics management is a critical component of pharmaceutical services that ensures the availability, quality, safety, and rational use of medicines. Inadequate logistics management may lead to stock shortages, overstocking, increased operational costs, and disruptions in healthcare services. This study aimed to analyze the drug logistics management system at Altara Simalingkar Clinic, encompassing planning, budgeting, procurement, receiving, storage, distribution, utilization, recording and reporting, as well as monitoring and evaluation. This study employed a descriptive qualitative approach. Data were collected through in-depth interviews, observations, and documentation involving a pharmacy assistant technician as the key informant directly responsible for the daily technical operations of drug logistics management. Data were analyzed thematically by comparing interview findings, observations, and supporting documents. The results showed that the drug logistics management system at Altara Simalingkar Clinic generally complied with pharmaceutical logistics management principles. Drug planning was based on previous utilization data, disease patterns, and evaluations of fast-moving and slow-moving medicines. Storage practices implemented the First Expired First Out  method, while recording and reporting activities were supported by a pharmacy management information system. However, three structural challenges were identified: delays in drug delivery from distributors, limited storage capacity that does not meet WHO Good Storage Practice standards, and discrepancies between physical stock and administrative records arising from the dual manual-digital recording system. To enhance the effectiveness and sustainability of pharmaceutical services, it is recommended to diversify distributors for critical medicines, fully digitize inventory recording through barcode implementation, and optimize storage infrastructure in accordance with applicable regulatory standards.